NHS National Generics Pharmaceuticals Transition 2023_1
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £99,290,712 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Deadline | 17 Feb 2023 |
| Procedure | open |
| OCID | ocds-h6vhtk-039687 |
Awards (60)
This procurement was awarded to 31 suppliers. Values shown are per-award; the notice total is £99,290,712.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord-UK Ltd shared | £57,604,995 | 4 May 2023 | active |
| Accord-UK Ltd shared | · | · | active |
| Amarox Limited shared | £57,604,995 | 4 May 2023 | active |
| Amarox Limited shared | · | · | active |
| Aristo Pharma Limited shared | £57,604,995 | 4 May 2023 | active |
| Aristo Pharma Limited shared | · | · | active |
| Aventis Pharma ltd t/a Sanofi shared | £57,604,995 | 4 May 2023 | active |
| Aventis Pharma ltd t/a Sanofi shared | · | · | active |
| Brown and Burk UK Ltd shared | · | · | active |
| Brown & Burk UK Ltd shared | £57,604,995 | 4 May 2023 | active |
| Consilient Health Ltd shared | £57,604,995 | 4 May 2023 | active |
| Consilient Health Ltd shared | · | · | active |
| Crescent Pharma Ltd shared | £57,604,995 | 4 May 2023 | active |
| Crescent Pharma Ltd shared | · | · | active |
| Day Lewis Medical Ltd shared | £57,604,995 | 4 May 2023 | active |
| Day Lewis Medical Ltd shared | · | · | active |
| Dr.Reddy's Laboratories (UK) Limited shared | £57,604,995 | 4 May 2023 | active |
| Dr.Reddy's Laboratories (UK) Limited shared | · | · | active |
| Drugsrus Ltd shared | £57,604,995 | 4 May 2023 | active |
| Drugsrus Ltd shared | · | · | active |
| Eramol (UK) Ltd shared | £57,604,995 | 4 May 2023 | active |
| Eramol (UK) Ltd shared | · | · | active |
| Fontus Health Ltd shared | £57,604,995 | 4 May 2023 | active |
| Fontus Health Ltd shared | · | · | active |
| Ipca Laboratories UK Ltd shared | £57,604,995 | 4 May 2023 | active |
| Ipca Laboratories UK Ltd shared | · | · | active |
| medac Pharma LLP shared | £57,604,995 | 4 May 2023 | active |
| medac Pharma LLP shared | · | · | active |
| Milpharm Ltd/aurobinbdo shared | £57,604,995 | 4 May 2023 | active |
| Milpharm Ltd/aurobinbdo shared | · | · | active |
| Neuraxpharm UK Ltd shared | £57,604,995 | 4 May 2023 | active |
| Neuraxpharm UK Ltd shared | · | · | active |
| Relonchem Ltd shared | £57,604,995 | 4 May 2023 | active |
| Relonchem Ltd shared | · | · | active |
| Resolution Chemicals Limited shared | £57,604,995 | 4 May 2023 | active |
| Resolution Chemicals Limited shared | · | · | active |
| Roma Pharmaceuticals Limited shared | £57,604,995 | 4 May 2023 | active |
| Roma Pharmaceuticals Limited shared | · | · | active |
| Sandoz Ltd shared | £57,604,995 | 4 May 2023 | active |
| Sandoz Ltd shared | · | · | active |
| Strandhaven Ltd t/a Somex Pharma shared | £57,604,995 | 4 May 2023 | active |
| Strandhaven Ltd t/a Somex Pharma shared | · | · | active |
| Sun Pharma UK Ltd shared | £57,604,995 | 4 May 2023 | active |
| Sun Pharma UK Ltd shared | · | · | active |
| Syri Limited (T/A Thame Laboratories) shared | £57,604,995 | 4 May 2023 | active |
| Syri Limited (T/A Thame Laboratories) shared | · | · | active |
| Teva UK Limited shared | £57,604,995 | 4 May 2023 | active |
| Teva UK Limited shared | · | · | active |
| Thea Pharmaceuticals Limited shared | £57,604,995 | 4 May 2023 | active |
| Thea Pharmaceuticals Limited shared | · | · | active |
| Thornton and Ross Ltd shared | £57,604,995 | 4 May 2023 | active |
| Thornton and Ross Ltd shared | · | · | active |
| Tillomed Laboratories ltd shared | £57,604,995 | 4 May 2023 | active |
| Tillomed Laboratories ltd shared | · | · | active |
| Waymade PLC shared | £57,604,995 | 4 May 2023 | active |
| Waymade PLC shared | · | · | active |
| Wockhardt UK Limited shared | £57,604,995 | 4 May 2023 | active |
| Wockhardt UK Limited shared | · | · | active |
| Zentiva Pharma UK Ltd shared | £57,604,995 | 4 May 2023 | active |
| Zentiva Pharma UK Ltd shared | · | · | active |
description
Framework agreement for NHS National Generics Pharmacuticals Transition 2023_1. Offer reference number CM/PHG/22/5666.<br/><br/>Potential periods of call-offs under the framework agreement:<br/> CM/PHG/22/5666/00 – Transition Products:<br/>CESW- /08/2023 – 31/01/2024 (6 months) <br/>NWLN 01/08/2023 – 31/01/2025 (18 months)<br/>LSNE 01/08/2023 – 31/05/2024 (10 months) <br/> <br/>CM/PHG/22/5666/01 – Orals (plus non-parenteral) Products: <br/>All regions: 01/08/2023 to 31/05/2024 (10 Months)
notice history
3 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 11 Jan 2023 | Contract notice (F02) | Earlier regulations | 000801-2023 |
| 24 May 2023 | Contract award notice (F03) | Earlier regulations | 014809-2023 |
| 24 May 2023 | Award (award) | · | 82b7505c-e6e7-47d8-bb19-a1290cc3a40d-647947 |
more from NHS England
- Urgent Award - haematological screening · £16,202 · 29 Jul 2026
- HSCN-AWS Connectivity Service for Spine · £228,060 · 29 Jul 2026
- Incentive Voucher Provider · £60,000 · 29 Jul 2026
- CRM for NHSE participant/candidate data 26-27 · £56,640 · 28 Jul 2026
- Wayfinder and First Contact Digital Clinical Support 2026-27 · £748,000 · 23 Jul 2026
- Support Services for PPM application · £860,000 · 22 Jul 2026
- Digital Maturity Assessment · 21 Jul 2026
- Integrated Healthcare Services to Haslar Immigration Removal Centre (IRC) · £19,052,186 · 13 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.